Margolin Richard A 4
4 · REVIVA PHARMACEUTICALS HOLDINGS, INC. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
Margolin Richard A
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-15+4,000→ 4,000 totalExercise: $4.73Exp: 2031-06-14→ Common Stock, par value $0.0001 per share (4,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The Option will vest at the rate of thirty-three percent (33%) of the shares subject thereto upon the one year anniversary of December 14, 2020, and as to an additional thirty-three percent (33%) of the shares subject to the Option on each successive one year anniversary thereafter, provided that Awardee remains a director of the Company through each such vesting date. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan.